1. Home
  2. CNX vs CORT Comparison

CNX vs CORT Comparison

Compare CNX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNX Resources Corporation

CNX

CNX Resources Corporation

HOLD

Current Price

$32.90

Market Cap

5.3B

Sector

Energy

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$116.24

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNX
CORT
Founded
1860
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
9.7B
IPO Year
1998
2001

Fundamental Metrics

Financial Performance
Metric
CNX
CORT
Price
$32.90
$116.24
Analyst Decision
Sell
Buy
Analyst Count
7
5
Target Price
$35.71
★ $96.50
AVG Volume (30 Days)
★ 1.5M
839.3K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 763.33
N/A
EPS
★ 3.56
0.09
Revenue
★ $2,239,134,000.00
$761,407,000.00
Revenue This Year
N/A
$26.08
Revenue Next Year
$11.14
$26.98
P/E Ratio
★ $9.38
$1,310.33
Revenue Growth
★ 76.76
12.79
52 Week Low
$31.47
$28.66
52 Week High
$43.62
$126.38

Technical Indicators

Market Signals
Indicator
CNX
CORT
Relative Strength Index (RSI) 32.19 54.08
Support Level $32.83 $108.33
Resistance Level $34.38 $124.30
Average True Range (ATR) 0.94 5.73
MACD -0.34 -0.03
Stochastic Oscillator 11.35 64.97

Price Performance

Historical Comparison
CNX
CORT

About CNX CNX Resources Corporation

CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: